Confirm a diagnosis, provide a better understanding of prognosis, and direct medical management
Help make healthy pregnancies possible with carrier screening and preimplantation testing
Determine a healthy adult’s predisposition to cancer, cardiovascular conditions, and more
The Invitae Network creates data-driven connections throughout the healthcare system to advance research and care.
*Order must be placed within 90 days of the original report
1. Christiaans I, et al. Update of genetic counseling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet. 2008;16(10):1201-7.
2. Sharaf RN, et al. Uptake of genetic testing by relatives of Lynch syndrome probands: A systematic review. Clin Gastroenterol Hepatol. 2013;11(9):1093-100.
3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment: Breast and Ovarian V.2.2017. © National Comprehensive Cancer Network, Inc 2016. All rights reserved. Accessed September 25, 2017. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
